129 related articles for article (PubMed ID: 10029288)
1. Non-transferrin-bound iron and cellular toxicity.
Anderson GJ
J Gastroenterol Hepatol; 1999 Feb; 14(2):105-8. PubMed ID: 10029288
[No Abstract] [Full Text] [Related]
2. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
McNamara L; MacPhail AP; Mandishona E; Bloom P; Paterson AC; Rouault TA; Gordeuk VR
J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
[TBL] [Abstract][Full Text] [Related]
3. Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation.
Cabantchik IZ; Hershko C
Am J Hematol; 2022 Jan; 97(1):7-9. PubMed ID: 34637551
[No Abstract] [Full Text] [Related]
4. Basal endocrine status in African dietary iron overload.
McNamara L; Panz VR; Raal FJ; Paiker J; Joffe BI; Gordeuk VR; MacPhail AP
Endocrine; 2003 Aug; 21(3):241-4. PubMed ID: 14515008
[TBL] [Abstract][Full Text] [Related]
5. Non-transferrin bound iron: a key role in iron overload and iron toxicity.
Brissot P; Ropert M; Le Lan C; Loréal O
Biochim Biophys Acta; 2012 Mar; 1820(3):403-10. PubMed ID: 21855608
[TBL] [Abstract][Full Text] [Related]
6. Role of non-transferrin-bound iron in the pathogenesis of iron overload and toxicity.
Brissot P; Loréal O
Adv Exp Med Biol; 2002; 509():45-53. PubMed ID: 12572988
[No Abstract] [Full Text] [Related]
7. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
Brunacci F; Rocha VS; De Carli E; Espósito BP; Ruano R; Colli C
Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and management of iron toxicity in thalassemia.
Hershko C
Ann N Y Acad Sci; 2010 Aug; 1202():1-9. PubMed ID: 20712765
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic strategy for iron overload in adults (excluding hematologic iron overload)].
Brissot P
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B88-9. PubMed ID: 10891770
[No Abstract] [Full Text] [Related]
10. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL
J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675
[TBL] [Abstract][Full Text] [Related]
11. [Syndrome of iron overload and its impact on the clinical course and risk of complications in patients with liver cirrhosis].
Mel'kina ES; Fedulenkova LA; Noskova KK; Petrakov AV; Varvanina GG; Drozdov VN
Eksp Klin Gastroenterol; 2011; (10):26-30. PubMed ID: 22629696
[TBL] [Abstract][Full Text] [Related]
12. Dietary Iron Overload Abrogates Chemically-Induced Liver Cirrhosis in Rats.
Atarashi M; Izawa T; Mori M; Inai Y; Kuwamura M; Yamate J
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30279328
[TBL] [Abstract][Full Text] [Related]
13. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
14. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
15. Iron Status and Gestational Diabetes-A Meta-Analysis.
Kataria Y; Wu Y; Horskjær PH; Mandrup-Poulsen T; Ellervik C
Nutrients; 2018 May; 10(5):. PubMed ID: 29762515
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of iron overload].
Deugnier Y; Gandon Y; Juhel C; Olivié D; Jouanolle AM; Turlin B
Rev Prat; 2006 Dec; 56(19):2118-22. PubMed ID: 17416048
[TBL] [Abstract][Full Text] [Related]
17. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
18. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
19. Transferrin saturation and mortality.
Benyamin B; Montgomery GW; Martin NG; Whitfield JB
Clin Chem; 2011 Jun; 57(6):921-3; author reply 923. PubMed ID: 21343418
[No Abstract] [Full Text] [Related]
20. [Pathogenesis of transfusional iron overload and iron chelation therapy].
Ozawa K
Rinsho Ketsueki; 2009 Jul; 50(7):527-31. PubMed ID: 19638719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
